Trial Profile
A case control, Multi-centre, Retrospective analysis Trial Evaluating the Compassionate Use of Ivacaftor in Patients with Cystic Fibrosis who carry the G551D Mutation and who had Severe Lung Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jan 2017
Price :
$35
*
At a glance
- Drugs Ivacaftor (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- 28 Dec 2015 New trial record